Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | SQLE | Q14534 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 5/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26977240 | 0.98 | LMNA (0.38) | SMN1; SMN2OPRM1SQLELMNAALDH1A1 | |
| SCHEMBL28985944 | 0.94 | ALDH1A1 (0.35) | SMN1; SMN2OPRM1SQLELMNAALDH1A1 | |
| SCHEMBL26976987 | 0.86 | ALDH1A1 (0.38) | ALDH1A1TSHRALOX15 | |
| SCHEMBL19480573 | 0.80 | LMNA (0.38) | LMNAALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL26977307 | 0.77 | ALDH1A1 (0.40) | ALDH1A1ALOX15 | |
| SCHEMBL26977351 | 0.76 | ALDH1A1 (0.47) | LMNAALDH1A1TSHRALOX15PTPN1 | |
| SCHEMBL26977237 | 0.76 | CES2 (0.35) | LMNAALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL8520818 | 0.75 | MAPT (0.37) | LMNAMEN1KMT2AFAAHMAPK1 | |
| SCHEMBL31538320 | 0.75 | OPRM1 (0.46) | SMN1; SMN2OPRM1LMNAALDH1A1MEN1 | |
| SCHEMBL8520817 | 0.75 | MAPT (0.37) | LMNAMEN1KMT2AFAAHMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12516012-B2 | Odorous compounds and method of preparation thereof | S.H. Kelkar and Company Limited (IN) | 2026-01-06 | — | — | US | claimed |
| CN-115803309-B | Odorous compounds and process for their preparation | 丝趣科尔卡有限公司 | 2024-10-11 | — | — | CN | claimed |
| US-20240262776-A1 | Odorous Compounds and Method of Preparation Thereof | S.H. Kelkar and Company Limited (IN) | 2024-08-08 | — | — | US | claimed |
| EP-4298078-A1 | ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF | S. H. Kelkar and Company Limited (IN) | 2024-01-03 | — | — | EP | claimed |
| CN-115803309-A | Odorous compounds and methods of making the same | 丝趣科尔卡有限公司 | 2023-03-14 | — | — | CN | claimed |
| WO-2022180642-A1 | ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF | S. H. KELKAR AND COMPANY LIMITED (IN) | 2022-09-01 | — | — | WO | claimed |
| US-12516012-B2 | Odorous compounds and method of preparation thereof | S.H. Kelkar and Company Limited (IN) | 2026-01-06 | — | — | US | disclosed |
| CN-115803309-B | Odorous compounds and process for their preparation | 丝趣科尔卡有限公司 | 2024-10-11 | — | — | CN | disclosed |
| US-20240262776-A1 | Odorous Compounds and Method of Preparation Thereof | S.H. Kelkar and Company Limited (IN) | 2024-08-08 | — | — | US | disclosed |
| EP-4298078-A1 | ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF | S. H. Kelkar and Company Limited (IN) | 2024-01-03 | — | — | EP | disclosed |
| CN-115803309-A | Odorous compounds and methods of making the same | 丝趣科尔卡有限公司 | 2023-03-14 | — | — | CN | disclosed |
| WO-2022180642-A1 | ODOROUS COMPOUNDS AND METHOD OF PREPARATION THEREOF | S. H. KELKAR AND COMPANY LIMITED (IN) | 2022-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240262776-A1 | Odorous Compounds and Method of Preparation Thereof | OR10J3, OR51E2, DECR1 | SMN1; SMN2 4486/4885OPRM1 77/4885SQLE 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.